Madopar Tafla 125 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

madopar tafla 125 mg

roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - tafla - 125 mg

Madopar Depot Hart forðahylki 100 mg/25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

madopar depot hart forðahylki 100 mg/25 mg

roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart forðahylki - 100 mg/25 mg

Madopar Quick Lausnartafla 100 mg/25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

madopar quick lausnartafla 100 mg/25 mg

roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 100 mg/25 mg

Madopar Quick Lausnartafla 50 mg/12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

madopar quick lausnartafla 50 mg/12,5 mg

roche pharmaceuticals a/s - levodopum inn; benserazidum hýdróklóríð - lausnartafla - 50 mg/12,5 mg

Puri-nethol Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

puri-nethol tafla 50 mg

aspen pharma trading limited - mercaptopurinum inn - tafla - 50 mg

Tolvaptan Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

tolvaptan accord

accord healthcare s.l.u. - tolvaptan - Óviðeigandi adh heilkenni - Þvagræsilyf, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).

Aubagio Evrópusambandið - íslenska - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - margvísleg sclerosis - valdar ónæmisbælandi lyf - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Teriflunomide Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi, sérhæfður ónæmisbælandi - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Flúoxetín Actavis Lausnartafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flúoxetín actavis lausnartafla 20 mg

actavis group ptc ehf. - fluoxetine hydrochloride - lausnartafla - 20 mg